SCHEMBL2861313

SCHEMBL2861313

Nc1nc2ccc(Oc3cccc(NC(=O)O)c3)nc2s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.49
PDGFRB P09619 1/20 0.49
KIT P10721 1/20 0.49
FLT1 P17948 1/20 0.49
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
HTT P42858 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
F2 P00734 1/20 0.39
F10 P00742 1/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
CDK8 P49336 2/20 0.39
POLB P06746 2/20 0.38
MITF O75030 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4293310 0.83 KDR (0.73) KDRPDGFRBKITFLT1NPC1
SCHEMBL2851294 0.81 KDR (0.56) KDRPDGFRBKITFLT1RAB9A
SCHEMBL2859622 0.81 KDR (0.72) KDRPDGFRBKITFLT1
SCHEMBL2855433 0.81 ALDH1A1 (0.40) KDRPDGFRBKITFLT1NPC1
SCHEMBL2861678 0.80 BRAF (0.53) KDRPDGFRBKITFLT1NPC1
SCHEMBL14949680 0.80 MET (0.44) KDRNPC1RAB9AALDH1A1LMNA
SCHEMBL2853481 0.80 EPHX2 (0.41) NPC1RAB9AALDH1A1LMNASMN1; SMN2
SCHEMBL4291526 0.80 L3MBTL1 (0.57) MAPTF2F10
SCHEMBL2853872 0.79 KDR (0.47) KDRPDGFRBKITFLT1MAPT
SCHEMBL21186282 0.79 NPC1 (0.55) NPC1RAB9AALDH1A1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2184285-B1 HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2015-11-04 EP disclosed
EP-2184285-A1 HETEROCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2010-05-12 EP disclosed